Published in J Physiol on January 27, 2005
Pharmacogenetics and anti-arrhythmic drug therapy: a theoretical investigation. Am J Physiol Heart Circ Physiol (2006) 1.23
A conserved ring of charge in mammalian Na+ channels: a molecular regulator of the outer pore conformation during slow inactivation. J Physiol (2006) 0.91
A molecular switch between the outer and the inner vestibules of the voltage-gated Na+ channel. J Biol Chem (2010) 0.90
Lidocaine reduces the transition to slow inactivation in Na(v)1.7 voltage-gated sodium channels. Br J Pharmacol (2011) 0.90
Transient inactivation of the ventral tegmental area selectively disrupts the expression of conditioned place preference for pup- but not cocaine-paired contexts. Behav Neurosci (2009) 0.88
Novel molecular determinants in the pore region of sodium channels regulate local anesthetic binding. Mol Pharmacol (2009) 0.79
Comparison of Gating Properties and Use-Dependent Block of Nav1.5 and Nav1.7 Channels by Anti-Arrhythmics Mexiletine and Lidocaine. PLoS One (2015) 0.77
Exploring the structure of the voltage-gated Na+ channel by an engineered drug access pathway to the receptor site for local anesthetics. J Biol Chem (2014) 0.75
Evaluation of the cardiotoxicity and resuscitation of rats of a newly developed mixture of a QX-314 analog and levobupivacaine. J Pain Res (2017) 0.75
A quantitative description of membrane current and its application to conduction and excitation in nerve. J Physiol (1952) 160.83
Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction. J Gen Physiol (1977) 12.38
Effects of external cations and mutations in the pore region on C-type inactivation of Shaker potassium channels. Receptors Channels (1993) 8.09
Two types of inactivation in Shaker K+ channels: effects of alterations in the carboxy-terminal region. Neuron (1991) 8.06
Tetraethylammonium blockade distinguishes two inactivation mechanisms in voltage-activated K+ channels. Proc Natl Acad Sci U S A (1991) 5.73
Molecular determinants of state-dependent block of Na+ channels by local anesthetics. Science (1994) 5.62
A cluster of hydrophobic amino acid residues required for fast Na(+)-channel inactivation. Proc Natl Acad Sci U S A (1992) 5.60
The effects of external potassium and long duration voltage conditioning on the amplitude of sodium currents in the giant axon of the squid, Loligo pealei. J Gen Physiol (1969) 5.32
Lidocaine block of cardiac sodium channels. J Gen Physiol (1983) 5.13
Mechanism of frequency-dependent inhibition of sodium currents in frog myelinated nerve by the lidocaine derivative GEA. J Pharmacol Exp Ther (1975) 5.07
Calcium channel characteristics conferred on the sodium channel by single mutations. Nature (1992) 4.90
An engineered cysteine in the external mouth of a K+ channel allows inactivation to be modulated by metal binding. Biophys J (1994) 4.33
Local anesthetic block of sodium channels in normal and pronase-treated squid giant axons. Biophys J (1978) 4.08
Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels. Proc Natl Acad Sci U S A (1996) 3.03
A novel persistent tetrodotoxin-resistant sodium current in SNS-null and wild-type small primary sensory neurons. J Neurosci (1999) 2.73
On the structural basis for ionic selectivity among Na+, K+, and Ca2+ in the voltage-gated sodium channel. Biophys J (1996) 2.39
Suppression of neuronal and cardiac transient outward currents by viral gene transfer of dominant-negative Kv4.2 constructs. J Biol Chem (1997) 2.04
Depth asymmetries of the pore-lining segments of the Na+ channel revealed by cysteine mutagenesis. Neuron (1996) 1.98
Mechanism for bupivacaine depression of cardiac conduction: fast block of sodium channels during the action potential with slow recovery from block during diastole. Anesthesiology (1985) 1.82
On the molecular nature of the lidocaine receptor of cardiac Na+ channels. Modification of block by alterations in the alpha-subunit III-IV interdomain. Circ Res (1995) 1.77
External pore residue mediates slow inactivation in mu 1 rat skeletal muscle sodium channels. J Physiol (1996) 1.75
Sodium channel selectivity filter regulates antiarrhythmic drug binding. Proc Natl Acad Sci U S A (1997) 1.61
Na channel activation gate modulates slow recovery from use-dependent block by local anesthetics in squid giant axons. Biophys J (1985) 1.58
Local anesthetics as effectors of allosteric gating. Lidocaine effects on inactivation-deficient rat skeletal muscle Na channels. J Clin Invest (1996) 1.54
The position of the fast-inactivation gate during lidocaine block of voltage-gated Na+ channels. J Gen Physiol (1999) 1.50
Inhibition of sodium currents by local anesthetics in chloramine-T-treated squid axons. The role of channel activation. J Gen Physiol (1987) 1.42
Ultra-slow inactivation in mu1 Na+ channels is produced by a structural rearrangement of the outer vestibule. Biophys J (1999) 1.33
Topology of the P segments in the sodium channel pore revealed by cysteine mutagenesis. Biophys J (1997) 1.30
A structural rearrangement in the sodium channel pore linked to slow inactivation and use dependence. J Gen Physiol (2000) 1.28
Role of domain 4 in sodium channel slow inactivation. J Gen Physiol (2000) 1.27
Altered ionic selectivity of the sodium channel revealed by cysteine mutations within the pore. J Gen Physiol (1997) 1.26
Mechanisms of sodium/calcium selectivity in sodium channels probed by cysteine mutagenesis and sulfhydryl modification. Biophys J (1997) 1.17
The selectivity filter of the voltage-gated sodium channel is involved in channel activation. J Biol Chem (2001) 1.16
Mechanistic link between lidocaine block and inactivation probed by outer pore mutations in the rat micro1 skeletal muscle sodium channel. J Physiol (1998) 1.09
Electrophysiological characteristics of cloned skeletal and cardiac muscle sodium channels. Am J Physiol (1996) 1.09
Molecular dynamics of the sodium channel pore vary with gating: interactions between P-segment motions and inactivation. J Neurosci (1999) 1.09
Molecular motions of the outer ring of charge of the sodium channel: do they couple to slow inactivation? J Gen Physiol (2003) 1.07
Lidocaine induces a slow inactivated state in rat skeletal muscle sodium channels. J Physiol (2000) 1.06
A critical residue for isoform difference in tetrodotoxin affinity is a molecular determinant of the external access path for local anesthetics in the cardiac sodium channel. Proc Natl Acad Sci U S A (2000) 1.05
Slow inactivation does not block the aqueous accessibility to the outer pore of voltage-gated Na channels. J Gen Physiol (2002) 1.02
Involvement of local anesthetic binding sites on IVS6 of sodium channels in fast and slow inactivation. Neurosci Lett (2003) 0.87
Relative sodium current block by bupivacaine and lidocaine in neonatal rat myocytes. Anesth Analg (1994) 0.81
Anesthesiology physician scientists in academic medicine: a wake-up call. Anesthesiology (2006) 7.53
Robust replication of genotype-phenotype associations across multiple diseases in an electronic medical record. Am J Hum Genet (2010) 6.44
Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes. Circulation (2002) 2.98
Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias. Circulation (2007) 2.50
A mutation in the human cardiac sodium channel (E161K) contributes to sick sinus syndrome, conduction disease and Brugada syndrome in two families. J Mol Cell Cardiol (2005) 2.21
Genetics of acquired long QT syndrome. J Clin Invest (2005) 1.96
Cardiac ion channels. Annu Rev Physiol (2002) 1.90
A calcium sensor in the sodium channel modulates cardiac excitability. Nature (2002) 1.83
Myocardial bundles with slow conduction properties are present on the left interventricular septal surface of normal human hearts. J Cardiovasc Electrophysiol (2004) 1.75
Oxidative mediated lipid peroxidation recapitulates proarrhythmic effects on cardiac sodium channels. Circ Res (2005) 1.70
Clinical, genetic, and biophysical characterization of SCN5A mutations associated with atrioventricular conduction block. Circulation (2002) 1.65
A sodium channel pore mutation causing Brugada syndrome. Heart Rhythm (2006) 1.64
An EF-hand in the sodium channel couples intracellular calcium to cardiac excitability. Nat Struct Mol Biol (2004) 1.59
Coronary sinus recordings of double potentials associated with retrograde conduction through left atrioventricular accessory pathways. J Cardiovasc Electrophysiol (2004) 1.47
Centralized oversight of physician-scientist faculty development at Vanderbilt: early outcomes. Acad Med (2008) 1.42
A common SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation. J Clin Invest (2003) 1.41
Atrial flutter after cavotricuspid isthmus ablation: what is the mechanism? J Cardiovasc Electrophysiol (2011) 1.38
Calcium-dependent regulation of the voltage-gated sodium channel hH1: intrinsic and extrinsic sensors use a common molecular switch. Proc Natl Acad Sci U S A (2006) 1.36
Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug. Exp Eye Res (2004) 1.35
Solution NMR structure of the C-terminal EF-hand domain of human cardiac sodium channel NaV1.5. J Biol Chem (2008) 1.32
Sex, age, and regional differences in L-type calcium current are important determinants of arrhythmia phenotype in rabbit hearts with drug-induced long QT type 2. Circ Res (2008) 1.30
Functional Interactions between Distinct Sodium Channel Cytoplasmic Domains through the Action of Calmodulin. J Biol Chem (2009) 1.22
Retracted Cytoskeletal disrupting agents prevent calmodulin kinase, IQ domain and voltage-dependent facilitation of L-type Ca2+ channels. J Physiol (2002) 1.16
Beyond Flexner: a new model for continuous learning in the health professions. Acad Med (2010) 1.15
New mechanism contributing to drug-induced arrhythmia: rescue of a misprocessed LQT3 mutant. Circulation (2005) 1.12
Does the prepotential truly reflect the activation preceding the development of ventricular arrhythmias? J Cardiovasc Electrophysiol (2015) 1.08
In vivo identification of genes that modify ether-a-go-go-related gene activity in Caenorhabditis elegans may also affect human cardiac arrhythmia. Proc Natl Acad Sci U S A (2004) 1.07
Quantitation of protein kinase A-mediated trafficking of cardiac sodium channels in living cells. Cardiovasc Res (2006) 1.07
Inherited sodium channelopathies: a continuum of channel dysfunction. Trends Cardiovasc Med (2004) 1.07
Typical atrial flutter with atypical flutter wave morphology due to abnormal interatrial conduction. Cardiol J (2011) 0.97
The IKr drug response is modulated by KCR1 in transfected cardiac and noncardiac cell lines. FASEB J (2003) 0.95
Extracellular sodium interacts with the HERG channel at an outer pore site. J Gen Physiol (2002) 0.95
Cardiac-enriched LIM domain protein fhl2 is required to generate I(Ks) in a heterologous system. Cardiovasc Res (2002) 0.94
Development of simple and efficient in Planta transformation method for wheat (Triticum aestivum L.) using Agrobacterium tumefaciens. J Biosci Bioeng (2006) 0.93
Potential role of isoketals formed via the isoprostane pathway of lipid peroxidation in ischemic arrhythmias. J Cardiovasc Pharmacol (2007) 0.85
Putative mechanism of a postpacing interval paradoxically shorter than the tachycardia cycle length. J Cardiovasc Electrophysiol (2011) 0.85
HERG is protected from pharmacological block by alpha-1,2-glucosyltransferase function. J Biol Chem (2006) 0.85
Perioperative genomics. Venturing into uncharted seas. Anesthesiology (2003) 0.85
Electroanatomically estimated length of slow pathway in atrioventricular nodal reentrant tachycardia. Heart Vessels (2014) 0.84
QT interval prolongation and torsade de pointes induced by propofol and hypoalbuminemia. Int Heart J (2010) 0.84
Marked high density lipoprotein deficiency due to apolipoprotein A-I Tomioka (codon 138 deletion). Atherosclerosis (2009) 0.84
Pseudo-postpacing interval of diastolic potential after entrainment pacing of remote bystander pathway in reentrant ventricular tachycardia. Heart Vessels (2013) 0.80
Genetic screening in C. elegans identifies rho-GTPase activating protein 6 as novel HERG regulator. J Mol Cell Cardiol (2008) 0.80
Regular atrial tachyarrhythmia with double coronary sinus potentials: what is the diagnosis? J Cardiovasc Electrophysiol (2012) 0.79
Absence of left atrium-coronary sinus musculature electrical connection at coronary sinus ostium unmasked by unique double coronary sinus potentials pattern. Intern Med (2011) 0.79
Novel molecular determinants in the pore region of sodium channels regulate local anesthetic binding. Mol Pharmacol (2009) 0.79
Histopathological verification for successful ablation of mitral isthmus ventricular tachycardia complicated with cardiac sarcoidosis. Intern Med (2012) 0.79
The evolutionarily conserved residue A653 plays a key role in HERG channel closing. J Physiol (2009) 0.78
Successful ablation of a unique left-sided accessory pathway. Intern Med (2014) 0.78
Is the targeted accessory pathway alive or dead? J Cardiovasc Electrophysiol (2010) 0.78
Identification and characterization of a compound that protects cardiac tissue from human Ether-à-go-go-related gene (hERG)-related drug-induced arrhythmias. J Biol Chem (2012) 0.78
Functional interaction between extracellular sodium, potassium and inactivation gating in HERG channels. J Physiol (2004) 0.78
Inherited sodium channelopathies: models for acquired arrhythmias? Am J Physiol Heart Circ Physiol (2002) 0.77
Augmentation of J wave following ventricular pause in "benign" early repolarization. Intern Med (2010) 0.75
V-A-A-V activation sequence at the onset of a long RP tachycardia: what is the mechanism? J Cardiovasc Electrophysiol (2014) 0.75
Pilsicainide-induced polymorphic ventricular tachycardia. Intern Med (2012) 0.75
[Current topics of tongue and oral cancer-swallowing ability after surgery]. Nihon Jibiinkoka Gakkai Kaiho (2012) 0.75
Idiopathic ventricular fibrillation associated with complete right bundle branch block? Intern Med (2014) 0.75
Progressive electrocardiographic changes in arrhythmogenic right ventricular cardiomyopathy. Intern Med (2011) 0.75
[Present status on and future aspects of head and neck neoplasms]. Nihon Jibiinkoka Gakkai Kaiho (2004) 0.75
Successful ablation of atypical atrioventricular nodal reentrant tachycardia from a noncoronary sinus of Valsalva. Int Heart J (2014) 0.75
Long RP' tachycardia with an initial A-A-V activation sequence: what is the mechanism? J Cardiovasc Electrophysiol (2011) 0.75
Spontaneous termination of permanent atrial fibrillation. Intern Med (2011) 0.75
Increase in internal defibrillation threshold during acute myocardial infarction. Intern Med (2010) 0.75
Detection of diastolic potentials around the mitral annulus of structurally normal human hearts. Int Heart J (2010) 0.75
Brugada-type ST-elevation associated with writhing of a reconstructed esophagus. Intern Med (2012) 0.75
Differential diagnosis of supraventricular tachycardia with ventriculoatrial dissociation during ventricular overdrive pacing. Pacing Clin Electrophysiol (2011) 0.75
[Current situations and problems of quality control for medical imaging display systems]. Nihon Hoshasen Gijutsu Gakkai Zasshi (2015) 0.75
Ventricular fibrillation following bidirectional tachycardia due to digitalis toxicity. Intern Med (2011) 0.75
Circadian variations in ST-segment elevation surrounding the spontaneous onset of ventricular fibrillation in Brugada syndrome. J Cardiovasc Electrophysiol (2011) 0.75
Scar-related atrial tachycardia associated with radiation therapy. Intern Med (2010) 0.75
Left-sided ICD implantation via right-sided venous access in a patient with left hemodialysis fistula. Intern Med (2010) 0.75
[Problems in legislation on the therapy and observation of mentally disordered offenders]. Seishin Shinkeigaku Zasshi (2003) 0.75
Spontaneous deceleration of persistent atrial flutter due to atrial remodeling. J Cardiovasc Electrophysiol (2010) 0.75
Polymorphic ventricular tachycardia complicated with Cushing syndrome. Intern Med (2011) 0.75
Pathology of a lesion ablated from inside the coronary sinus. J Cardiovasc Electrophysiol (2014) 0.75
Torsades de pointes mimicking monomorphic ventricular tachycardia. Intern Med (2010) 0.75
Inappropriate therapy delivered by a CRT-D for tachycardia with simultaneous atrial and ventricular activation: what is the tachycardia? Pacing Clin Electrophysiol (2011) 0.75
New treatments for perioperative cardiac arrhythmias. Anesthesiol Clin North America (2003) 0.75
Marked lipomatous hypertrophy of the right ventricular wall: a distinct clinicopathological entity from arrhythmogenic right ventricular cardiomyopathy? Int J Cardiol (2011) 0.75
Right ventricular fatty infiltration associated with cardiac sudden death. Intern Med (2013) 0.75
Polymorphism of ventricular tachycardia due to variable exit from a single arrhythmogenic focus in the right ventricular outflow tract. J Cardiovasc Electrophysiol (2012) 0.75
Arrhythmogenic isthmus bounded with post-surgical right ventricular aneurysm. Intern Med (2015) 0.75
Reciprocal induction of long RP and wide QRS tachycardias. Pacing Clin Electrophysiol (2011) 0.75
Confirmation of non-ischemic etiology of left ventricular aneurysm. Intern Med (2010) 0.75
Discrimination between His-bundle and the right bundle branch during electrophysiologic studies. Pacing Clin Electrophysiol (2009) 0.75
Idiopathic ventricular fibrillation triggered by premature atrial complexes. J Cardiovasc Electrophysiol (2014) 0.75
Characteristics of systolic and diastolic potentials recorded in the left interventricular septum in verapamil-sensitive left ventricular tachycardia. Cardiol J (2012) 0.75
Onset of reentrant ventricular tachycardia modulated by variable impulse propagation through the zone of slow conduction. Intern Med (2011) 0.75
[Problems in forensic psychiatry--psychiatric evaluation of a criminal case with personality disorder]. Seishin Shinkeigaku Zasshi (2008) 0.75
Unintentional protrusion and trapping of the screw-in helix of an implantable cardioverter defibrillator lead. J Cardiovasc Electrophysiol (2010) 0.75
Mechanism of shorter postpacing interval than the tachycardia cycle after high-output entrainment pacing of atrial flutter. J Cardiovasc Electrophysiol (2013) 0.75
[Laser-radiation therapy for T2N0M0 laryngeal-glottic cancer]. Nihon Igaku Hoshasen Gakkai Zasshi (2002) 0.75